PNC Financial Services Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-170
| Closed | – | – | 4677 |
|
|
2022
Q2 | $0 | Sell |
170
-1,038
| -86% | -$915 | ﹤0.01% | 4813 |
|
|
2022
Q1 | $2K | Sell |
1,208
-2,841
| -70% | -$2.62K | ﹤0.01% | 4259 |
|
|
2021
Q4 | $5K | Sell |
4,049
-2,638
| -39% | -$4.72K | ﹤0.01% | 3993 |
|
|
2021
Q3 | $14K | Sell |
6,687
-4,115
| -38% | -$11.2K | ﹤0.01% | 3653 |
|
|
2021
Q2 | $40K | Buy |
10,802
+1,270
| +13% | +$4.41K | ﹤0.01% | 3189 |
|
|
2021
Q1 | $31K | Sell |
9,532
-611
| -6% | -$2.19K | ﹤0.01% | 3229 |
|
|
2020
Q4 | $35K | Buy |
10,143
+438
| +5% | +$1.8K | ﹤0.01% | 3106 |
|
|
2020
Q3 | $38K | Buy |
9,705
+143
| +1% | +$544 | ﹤0.01% | 2887 |
|
|
2020
Q2 | $31K | Sell |
9,562
-2,478
| -21% | -$7.22K | ﹤0.01% | 3006 |
|
|
2020
Q1 | $27K | Buy |
12,040
+3,113
| +35% | +$8.52K | ﹤0.01% | 2965 |
|
|
2019
Q4 | $33K | Sell |
8,927
-2,673
| -23% | -$21.6K | ﹤0.01% | 3125 |
|
|
2019
Q3 | $96K | Buy |
11,600
+1,056
| +10% | +$8.54K | ﹤0.01% | 2565 |
|
|
2019
Q2 | $91K | Buy |
10,544
+5,711
| +118% | +$51.1K | ﹤0.01% | 2594 |
|
|
2019
Q1 | $52K | Sell |
4,833
-2,041
| -30% | -$21.9K | ﹤0.01% | 2935 |
|
|
2018
Q4 | $60K | Buy |
6,874
+698
| +11% | +$8.89K | ﹤0.01% | 2771 |
|
|
2018
Q3 | $104K | Buy |
6,176
+1,283
| +26% | +$27.8K | ﹤0.01% | 2580 |
|
|
2018
Q2 | $103K | Buy |
4,893
+419
| +9% | +$7.76K | ﹤0.01% | 2580 |
|
|
2018
Q1 | $72K | Buy |
4,474
+1,297
| +41% | +$25.7K | ﹤0.01% | 2752 |
|
|
2017
Q4 | $60K | Buy |
3,177
+2,609
| +459% | +$47.3K | ﹤0.01% | 2843 |
|
|
2017
Q3 | $8K | Buy |
568
+344
| +154% | +$3.11K | ﹤0.01% | 3767 |
|
|
2017
Q2 | $2K | Buy |
224
+118
| +111% | +$771 | ﹤0.01% | 4027 |
|
|
2017
Q1 | $1K | Buy |
+106
| New | +$593 | ﹤0.01% | 4063 |
|
|
2016
Q1 | – | Sell |
-1,215
| Closed | -$7K | – | 4592 |
|
|
2015
Q4 | $7K | Sell |
1,215
-5,077
| -81% | -$29K | ﹤0.01% | 3754 |
|
|
2015
Q3 | $38K | Buy |
6,292
+5,077
| +418% | +$35.2K | ﹤0.01% | 3041 |
|
|
2015
Q2 | $8K | Sell |
1,215
-7,085
| -85% | -$45K | ﹤0.01% | 3891 |
|
|
2015
Q1 | $50K | Sell |
8,300
-2,767
| -25% | -$18.4K | ﹤0.01% | 3047 |
|
|
2014
Q4 | $77K | Sell |
11,067
-1,096
| -9% | -$8.06K | ﹤0.01% | 2611 |
|
|
2014
Q3 | $98K | Hold |
12,163
| – | – | ﹤0.01% | 2388 |
|
|
2014
Q2 | $98K | Hold |
12,163
| – | – | ﹤0.01% | 2291 |
|
|
2014
Q1 | $95K | Buy |
12,163
+10,067
| +480% | +$85.2K | ﹤0.01% | 2239 |
|
|
2013
Q4 | $19K | Sell |
2,096
-834
| -28% | -$7.45K | ﹤0.01% | 2815 |
|
|
2013
Q3 | $25K | Hold |
2,930
| – | – | ﹤0.01% | 2758 |
|
|
2013
Q2 | $22K | Buy |
+2,930
| New | +$22.5K | ﹤0.01% | 2711 |
|
Other funds holding SPPI
AC
PNC Financial Services Group's SPPI Position: Q3 2022 in Review
PNC Financial Services Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 170 shares.
PNC Financial Services Group first reported a position in SPPI in Q2 2013 and held it in 33 quarters. The position peaked at $104K in Q3 2018. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.
- PNC Financial Services Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
- PNC Financial Services Group sold 170 Spectrum Pharmaceuticals Inc shares in Q3 2022.
- PNC Financial Services Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
- PNC Financial Services Group's Spectrum Pharmaceuticals Inc position peaked at $104K in Q3 2018.
- 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.
Based on PNC Financial Services Group's 13F filing for Q3 2022, filed 10 Nov 2022.